ArticleFrontiers in oncology2021

Inflammatory Markers and Procalcitonin Predict the Outcome of Metastatic Non-Small-Cell-Lung-Cancer Patients Receiving PD-1/PD-L1 Immune-Checkpoint Blockade.

Valerio Nardone et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.